Siemens Healthineers AG
SEMHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.69 | 5.60 | 2.29 | -1.29 |
| FCF Yield | 1.56% | 1.46% | 0.12% | 1.32% |
| EV / EBITDA | 24.48 | 54.46 | 62.95 | 69.50 |
| Quality | ||||
| ROIC | 2.03% | 1.83% | 1.72% | 1.44% |
| Gross Margin | 37.97% | 38.52% | 39.31% | 39.26% |
| Cash Conversion Ratio | 1.58 | 1.73 | 0.49 | 1.97 |
| Growth | ||||
| Revenue 3-Year CAGR | 8.16% | 2.64% | 2.31% | 1.43% |
| Free Cash Flow Growth | 2.62% | 1,041.79% | -91.23% | -25.54% |
| Safety | ||||
| Net Debt / EBITDA | -0.71 | 11.01 | 12.59 | 13.46 |
| Interest Coverage | 6.02 | 8.38 | 8.61 | 6.77 |
| Efficiency | ||||
| Inventory Turnover | 1.58 | 0.79 | 0.80 | 0.72 |
| Cash Conversion Cycle | 76.15 | 157.79 | 156.81 | 171.28 |